Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol

被引：13
|
作者：
Marks, Lianna J. [1 ]
McCarten, Kathleen M. [2 ]
Pei, Qinglin [3 ,4 ]
Friedman, Debra L. [5 ]
Schwartz, Cindy L. [6 ]
Kelly, Kara M. [7 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave,Box 139, New York, NY 10065 USA
[2] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[3] Univ Florida, Childrens Oncol Grp Stat, Gainesville, FL USA
[4] Univ Florida, Ctr Data, Gainesville, FL USA
[5] Vanderbilt Univ, Dept Pediat, Nashville, TN USA
[6] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[7] Roswell Pk Canc Inst, Dept Pediat, Buffalo, NY 14263 USA
来源：
BLOOD | 2018年 / 132卷 / 11期
基金：
美国国家卫生研究院;
关键词：
DISEASE; INVOLVEMENT; CT;
D O I：
10.1182/blood-2018-02-834465
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1208 / 1211
页数：4
相关论文
共 50 条
  • [41] Prognostic Value of Baseline Metabolic Tumor Volume in Intermediate-Risk Hodgkin Lymphoma After Chemo-radiation Therapy: FDG PET Parameter Analysis in a Subgroup from COG AHOD0031
    Milgrom, Sarah
    Kim, Jihyun
    Chirindel, Alin
    Kim, Jongho
    Pei, Qinglin
    Chen, Lu
    Buxton, Allen
    Kessel, Sandy
    Leal, Jeffrey
    McCarten, Kathleen
    Hoppe, Bradford
    Wolden, Suzanne
    Schwartz, Cindy
    Friedman, Debra
    Kelly, Kara
    Cho, Steve
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S36 - S36
  • [42] Patterns of Relapse From a Phase 3 Study of Response-Based Therapy for Intermediate-Risk Hodgkin Lymphoma (AH0D0031): A Report From the Children's Oncology Group
    Dharmarajan, Kavita V.
    Friedman, Debra L.
    Schwartz, Cindy L.
    Chen, Lu
    FitzGerald, T. J.
    McCarten, Kathleen M.
    Kessel, Sandy K.
    Iandoli, Matt
    Constine, Louis S.
    Wolden, Suzanne L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (01): : 60 - 66
  • [43] PHASE III STUDY OF RESPONSE ADAPTED THERAPY FOR THE TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED VERY HIGH RISK HODGKIN LYMPHOMA (STAGES IIIB/IVB) (AHOD0831): A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
    Kelly, K.
    Cole, P. D.
    Chen, L.
    Roberts, K. B.
    Hodgson, D. C.
    McCarten, K.
    Cho, S. Y.
    Schwartz, C. L.
    HAEMATOLOGICA, 2016, 101 : 34 - 34
  • [44] Massive pericardial effusion as the first manifestation of childhood non-Hodgkin's lymphoma: A case report
    Alizadeh, Behzad
    Shaye, Zahra
    Badiea, Zahra
    Dehghanian, Paria
    CLINICAL CASE REPORTS, 2021, 9 (11):
  • [45] Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group
    Kelly, Kara M.
    Cole, Peter D.
    Chen, Lu
    Roberts, Kenneth B.
    Hodgson, David C.
    McCarten, Kathleen
    Cho, Steve Y.
    Schwartz, Cindy
    BLOOD, 2015, 126 (23)
  • [46] Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group
    Isakoff, Michael S.
    Goldsby, Robert
    Villaluna, Doojduen
    Krailo, Mark D.
    Gorlick, Richard
    Doski, John J.
    Womer, Richard B.
    Janeway, Katherine A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 370 - 371
  • [47] Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: A Children's Oncology Group report (vol 62, pg 60, 2015)
    Trippett, T. M.
    Schwartz, C. L.
    Guillerman, R. P.
    Gamis, A. S.
    Gardner, S.
    Hogan, S.
    London, W. B.
    Chen, L.
    de Alarcon, P.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 927 - 927
  • [48] Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group
    Marks, Lianna J.
    Pei, Qinglin
    Bush, Rizvan
    Buxton, Allen
    Appel, Burton
    Kelly, Kara M.
    Schwartz, Cindy L.
    Friedman, Debra L.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (12)
  • [49] Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group
    Vega, Raymond B. Mailhot
    Harker-Murray, Paul D.
    Forlenza, Christopher J.
    Cole, Peter
    Kelly, Kara M.
    Milgrom, Sarah A.
    Parikh, Rahul R.
    Hodgson, David C.
    Castellino, Sharon M.
    Kahn, Justine
    Roberts, Kenneth B.
    Constine, Louis S.
    Hoppe, Bradford S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : 400 - 403
  • [50] Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study
    Parsons, Susan K.
    Rodday, Angie Mae
    Pei, Qinglin
    Keller, Frank G.
    Wu, Yue
    Henderson, Tara O.
    Cella, David
    Kelly, Kara M.
    Castellino, Sharon M.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
12345